Titan Pharmaceuticals Inc

Titan Pharmaceuticals — Fact Sheet (March 2015)

5 slides from Titan Pharmaceuticals's fact sheet, Mar 9, 2015

  1. Slide 1: Company Fact Sheet: Titan Pharmaceuticals Overview

    Exhibit 99.1 COMPANY FACT SHEET Titan Pharmaceuticals Overview Titan Pharmaceuticals Inc. (TTNP.OB), based in South San Francisco, CA, is a specialty phar-maceutical company developing proprietary therapeutics utilizing its ProNeura™ implant drug delivery technology. ProNeura provides non-fluc-tuati

  2. Slide 2: Slide 2

  3. Slide 3: Slide 3

  4. Slide 4: Probuphine Clinical Development & Commercialization Program

    Probuphine Clinical Development & Commercialization Program A final Phase 3 trial of Probuphine is in progress, with results expected by mid-2015. Pa-tient enrollment is complete in this two-arm double blind, double dummy, non-inferiority study in stable patients receiving maintenance treatment with

  5. Slide 5: Slide 5

Titan Pharmaceuticals — Fact Sheet (March 2015) on 6ix